Sources | Names Used |
---|---|
GDSC1000 | MPS-1-IN-1 |
PharmacoGx | MPS-1-IN-1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CBLN3 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
mRNA | OLFM1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | MRPS21 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
mRNA | IFT20 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
mRNA | PTBP2 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | UTP11 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
mRNA | PPM1K | GDSC1000 | pan-cancer | AAC | -0.099 | 0.01 |
mRNA | NPY1R | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | RNASE2 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
mRNA | PNPLA8 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |